Ross Hoffman, MD
Chief Medical Officer
- Recent former Fortune 25 Chief Medical Officer, Pharmacy and Innovation, Centene Corporation, covering 28M members, since 2015. >$140B total revenue, $40B annual pharmacy spend.
- Industry leadership in health policy committees, pharma and device innovation work groups and advisory roles at leading organizations across the US Healthcare ecosystem.
- Serial healthcare focused startup founder.
- MD (Cardiology) with training from University of Pennsylvania, University of Florida, Brown University and Harvard's Brigham and Women's/Boston Children's Hospital.
Physician entrepreneur, cardiologist, medical device and healthcare IT startup founder who served as Chief Medical Officer, Pharmacy/Innovation at Centene Corporation. Duties have included clinical and business leadership with health plans, product development teams, PBM and specialty pharmacy businesses, and corporate development teams. Dr. Hoffman led clinical programs concerning high-cost pharmaceuticals, cell and gene therapy, new technologies and procedures, and chronic care innovations. He advises investors, pharmaceutical, biotech and technology companies, health policy leaders, start-ups, and innovation incubators. He is a frequently invited guest speaker on high-cost drug access and affordability, health policy, value-based design, clinical care and network redesign, alternative payment models (re-insurance, stop-loss, warranties) and emerging (digital and muti-omic) novel diagnostics.
Dr. Hoffman contributes to global health initiatives through medical mission work and philanthropy.